Presentation is loading. Please wait.

Presentation is loading. Please wait.

Risk of mortality in patients with diabetes and ESRD

Published byMarkus Järvenpää Modified over 5 years ago

Similar presentations

Presentation on theme: "Risk of mortality in patients with diabetes and ESRD"— Presentation transcript:

1 Risk of mortality in patients with diabetes and ESRD
Risk of mortality in patients with diabetes and ESRD. A: Risk of mortality by initial A1C, adjusted for age, sex, race, BMI, years of dialysis, albumin, creatinine, 10 comorbid conditions, insulin use, hemoglobin, HDL cholesterol, country, and study phase. Risk of mortality in patients with diabetes and ESRD. A: Risk of mortality by initial A1C, adjusted for age, sex, race, BMI, years of dialysis, albumin, creatinine, 10 comorbid conditions, insulin use, hemoglobin, HDL cholesterol, country, and study phase. B: Risk of mortality by mean A1C, adjusted for age, sex, race, BMI, years of dialysis, albumin, creatinine, 10 comorbid conditions, insulin use, hemoglobin, HDL cholesterol, country, and study phase. Reproduced with permission from ADA (68). Katherine R. Tuttle et al. Dia Care 2014;37: ©2014 by American Diabetes Association

Download ppt "Risk of mortality in patients with diabetes and ESRD"

Similar presentations

Lynda K. Ball, MSN, RN, CNN Quality Improvement Director Northwest Renal Network Improving Sub-Optimal Hemoglobins October 14, 2010.

Lynda K. Ball, MSN, RN, CNN Quality Improvement Director Northwest Renal Network Improving Sub-Optimal Hemoglobins October 14, 2010.
Primary Cause of Kidney Failure in new ESRD patients at initiation, by ethnicity figure 2.1, 1997-2000 combined.

Primary Cause of Kidney Failure in new ESRD patients at initiation, by ethnicity figure 2.1, combined.
Diabetic Kidney Disease: A Report From an ADA Consensus Conference

Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Volume 69, Issue 11, Pages (June 2006)

Volume 69, Issue 11, Pages (June 2006)
Adjusted all-cause mortality risk by dialysate sodium (DNa) and predialysis serum sodium (SNa). Adjusted all-cause mortality risk by dialysate sodium (DNa)

Adjusted all-cause mortality risk by dialysate sodium (DNa) and predialysis serum sodium (SNa). Adjusted all-cause mortality risk by dialysate sodium (DNa)
Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.
Screening, enrollment, and randomization of study participants (BMI, body mass index; CTG, conventional therapy group; HbA1c, glycated hemoglobin; HDL-C,

Screening, enrollment, and randomization of study participants (BMI, body mass index; CTG, conventional therapy group; HbA1c, glycated hemoglobin; HDL-C,
Volume 68, Issue 6, Pages (December 2005)

Volume 68, Issue 6, Pages (December 2005)
NAFLD (nonalcoholic fatty liver disease), CVD, and type 2 diabetes: Details of the study design Targher G et al. Diabetes Care 2007;30:1212-8.

NAFLD (nonalcoholic fatty liver disease), CVD, and type 2 diabetes: Details of the study design Targher G et al. Diabetes Care 2007;30:
Survival advantage in Asian American end-stage renal disease patients1

Survival advantage in Asian American end-stage renal disease patients1
Changes in weight and body mass index (BMI) associated with quality improvement. Changes in weight and body mass index (BMI) associated with quality improvement.

Changes in weight and body mass index (BMI) associated with quality improvement. Changes in weight and body mass index (BMI) associated with quality improvement.
Volume 92, Issue 2, Pages (August 2017)

Volume 92, Issue 2, Pages (August 2017)
Patient characteristics: American vs Canadian transplant patients

Patient characteristics: American vs Canadian transplant patients
Adjusted OR and SE for BMI≥30 kg/m2, BMI 25–29. 9 kg/m2, HbA1c≥6

Adjusted OR and SE for BMI≥30 kg/m2, BMI 25–29. 9 kg/m2, HbA1c≥6
Association between antibiotic purchases and glycated hemoglobin (HbA1c) values in patients with and without diabetic nephropathy. Association between.

Association between antibiotic purchases and glycated hemoglobin (HbA1c) values in patients with and without diabetic nephropathy. Association between.
Relative risk of a major coronary heart disease event (myocardial infarction incidence, fatal coronary heart disease, or coronary revascularization) for.

Relative risk of a major coronary heart disease event (myocardial infarction incidence, fatal coronary heart disease, or coronary revascularization) for.
Persistent organic pollutants and diabetes - Spearman correlation coefficients* among six POPs with age, sex, race and ethnicity, poverty income.

Persistent organic pollutants and diabetes - Spearman correlation coefficients* among six POPs with age, sex, race and ethnicity, poverty income.
Relationships between annual antibiotic purchase rates and progression of microalbuminuria in patients with type 1 diabetes. Relationships between annual.

Relationships between annual antibiotic purchase rates and progression of microalbuminuria in patients with type 1 diabetes. Relationships between annual.
Temporal patterns of insulin sensitivity (A), C-peptide index (B), C-peptide oDI (C), and HMWA (D) in the three racial/ethnic groups with the three treatments.

Temporal patterns of insulin sensitivity (A), C-peptide index (B), C-peptide oDI (C), and HMWA (D) in the three racial/ethnic groups with the three treatments.
The rates of occurrences of cardiovascular, cerebrovascular, and all events expressed in cases per 1, 000 patient-years in diabetic subgroups divided by.

The rates of occurrences of cardiovascular, cerebrovascular, and all events expressed in cases per 1, 000 patient-years in diabetic subgroups divided by.

Similar presentations

Ads by Google